CEO of MEDNAX says cross-selling opportunities are "compelling"
Researchers say prostate cancer not a "single disease" but 90 percent of cases yield actionable mutations
Will jump from $3.2 billion to $20 billion
Research funded by feds to save lives offers faster, cheaper testing
'Wearing your heart on your sleeve' may take on a whole new meaning